Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.3 CAD | +0.70% | +0.23% | +40.98% |
06-26 | Kneat.com, Korber Pharma Consulting Join Forces on Digitalization Efforts | MT |
06-26 | Kneat Brief: Kneat and Korber Pharma Consulting Partnering On Digitalization | MT |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 164.7 | 190.1 | 304.5 | 207.1 | 238.7 | 365.5 | - | - |
Enterprise Value (EV) 1 | 162 | 181.7 | 290.8 | 201.9 | 251.6 | 370.4 | 374.9 | 384.9 |
P/E ratio | -24.9 x | -31.3 x | -30.5 x | -22.3 x | -16.9 x | -27.8 x | -35.6 x | 427 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | 41.7 x | 25.6 x | 19.6 x | 8.72 x | 6.97 x | 7.66 x | 5.7 x | 4.07 x |
EV / Revenue | 41 x | 24.5 x | 18.8 x | 8.5 x | 7.35 x | 7.76 x | 5.84 x | 4.28 x |
EV / EBITDA | -53 x | -52.1 x | -263 x | -68.8 x | -77.1 x | 157 x | 38.7 x | 30 x |
EV / FCF | -59.2 x | - | - | -22.6 x | -173 x | -37.9 x | -52.6 x | -175 x |
FCF Yield | -1.69% | - | - | -4.42% | -0.58% | -2.64% | -1.9% | -0.57% |
Price to Book | - | - | - | 7.98 x | 16.1 x | 13.3 x | 12.6 x | 10.4 x |
Nbr of stocks (in thousands) | 60,119 | 67,417 | 76,899 | 77,568 | 78,265 | 85,594 | - | - |
Reference price 2 | 2.740 | 2.820 | 3.960 | 2.670 | 3.050 | 4.270 | 4.270 | 4.270 |
Announcement Date | 22/04/20 | 23/02/21 | 23/02/22 | 22/02/23 | 21/02/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 3.95 | 7.422 | 15.5 | 23.75 | 34.22 | 47.74 | 64.16 | 89.9 |
EBITDA 1 | -3.057 | -3.487 | -1.106 | -2.936 | -3.265 | 2.36 | 9.68 | 12.85 |
EBIT 1 | - | - | - | -9.774 | -13.53 | -12.29 | -15.59 | - |
Operating Margin | - | - | - | -41.16% | -39.55% | -25.75% | -24.3% | - |
Earnings before Tax (EBT) 1 | -6.197 | - | -9.838 | -9.132 | -14.06 | -14.53 | -14.83 | - |
Net income 1 | -6.197 | -5.691 | -9.859 | -9.148 | -14.12 | -14.54 | -14.83 | - |
Net margin | -156.88% | -76.68% | -63.6% | -38.52% | -41.26% | -30.46% | -23.12% | - |
EPS 2 | -0.1100 | -0.0900 | -0.1300 | -0.1200 | -0.1800 | -0.1533 | -0.1200 | 0.0100 |
Free Cash Flow 1 | -2.738 | - | - | -8.918 | -1.457 | -9.783 | -7.127 | -2.2 |
FCF margin | -69.31% | - | - | -37.55% | -4.26% | -20.49% | -11.11% | -2.45% |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 22/04/20 | 23/02/21 | 23/02/22 | 22/02/23 | 21/02/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 6.263 | 5.2 | 5.548 | 5.752 | 7.25 | 7.965 | 8.039 | 8.405 | 9.814 | 10.77 | 11.54 | 12.13 | 13.47 | 14.5 | 15.3 |
EBITDA 1 | 1.099 | -0.0643 | -0.7039 | -0.8896 | -1.281 | -1.094 | -1.281 | -0.5361 | - | 0.5878 | -0.0702 | 0.8316 | 1.195 | 2.9 | 2.8 |
EBIT 1 | - | - | - | -2.527 | -3.281 | -3.351 | -3.944 | -3.177 | -3.062 | -2.25 | -3.37 | -3.126 | -3.547 | - | - |
Operating Margin | - | - | - | -43.94% | -45.25% | -42.07% | -49.06% | -37.8% | -31.2% | -20.9% | -29.2% | -25.76% | -26.34% | - | - |
Earnings before Tax (EBT) 1 | -1.529 | -3.426 | -3.634 | -2.547 | 0.4755 | -2.466 | -5.399 | -3.591 | -2.607 | -3.321 | -3.782 | -3.528 | -3.894 | - | - |
Net income 1 | -1.55 | -3.426 | -3.634 | -2.547 | 0.4589 | -2.474 | -5.399 | -3.591 | -2.655 | -3.337 | -3.788 | -3.352 | -3.563 | - | - |
Net margin | -24.74% | -65.89% | -65.5% | -44.28% | 6.33% | -31.07% | -67.15% | -42.73% | -27.05% | -30.99% | -32.82% | -27.63% | -26.46% | - | - |
EPS 2 | -0.0200 | -0.0400 | -0.0500 | -0.0300 | 0.0100 | -0.0300 | -0.0700 | -0.0500 | -0.0300 | -0.0400 | -0.0467 | -0.0333 | -0.0300 | - | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 23/02/22 | 11/05/22 | 10/08/22 | 09/11/22 | 22/02/23 | 09/05/23 | 08/08/23 | 08/11/23 | 21/02/24 | 08/05/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | 12.9 | 4.9 | 9.45 | 19.4 |
Net Cash position 1 | 2.74 | 8.38 | 13.7 | 5.19 | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | -3.956 x | 2.078 x | 0.9767 x | 1.51 x |
Free Cash Flow 1 | -2.74 | - | - | -8.92 | -1.46 | -9.78 | -7.13 | -2.2 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share 2 | - | - | - | 0.3300 | 0.1900 | 0.3200 | 0.3400 | 0.4100 |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex 1 | - | 0.5 | 0.65 | 0.33 | 0.18 | 0.5 | - | - |
Capex / Sales | - | 6.78% | 4.17% | 1.4% | 0.53% | 1.05% | - | - |
Announcement Date | 22/04/20 | 23/02/21 | 23/02/22 | 22/02/23 | 21/02/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.98% | 267M | |
+34.00% | 381B | |
+34.38% | 230B | |
+9.93% | 155B | |
+19.39% | 59.86B | |
+27.46% | 36.33B | |
+0.41% | 28.97B | |
+140.90% | 25.86B | |
+30.48% | 21.1B | |
+42.14% | 14.28B |
- Stock Market
- Equities
- KSI Stock
- Financials kneat.com, inc.